2025
· 28
BOS · SF
ROLE | ESTIMATED +/- | EFFICIENCY | LOCATION | REBS | HANDLE | DEFENSE | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Season · Age | GP | MPG | USG | OFF | DEF | EPM | EW | TS% | eFG% | Rim% | Mid% | 3PT% | FT% | OR% | DR% | AST% | TO% | ST% | BL% |
2025
· 28 BOS · SF | 47 /56 | 35.1 95 | 28.4 94 | +1.5 86 | −0.7 30 | +0.8 77 | 4.2 86 | 55.4 41 | 4.5 52 | 13.9 53 | 21.5 81 | 11.4 59 | 1.6 54 | 0.7 16 | |||||
2024
· 27 BOS · SF | 70 /82 | 33.5 91 | 28.4 95 | +1.4 87 | +1.1 87 | +2.5 92 | 8.8 94 | 58.4 58 | 4.1 51 | 13.2 47 | 16.5 69 | 10.7 60 | 1.7 70 | 1.4 43 | |||||
2023
· 26 BOS · SF | 67 /82 | 35.9 97 | 30.8 97 | +1.5 88 | +0.9 85 | +2.5 91 | 9.0 92 | 58.5 54 | 3.5 46 | 17.0 70 | 16.3 69 | 11.4 56 | 1.5 60 | 0.9 28 | |||||
2022
· 25 BOS · SF | 66 /82 | 33.6 91 | 29.9 97 | +1.8 91 | +0.7 81 | +2.5 92 | 8.4 93 | 57.6 60 | 2.7 35 | 16.3 66 | 17.3 73 | 11.6 50 | 1.5 54 | 0.7 19 | |||||
2021
· 24 BOS · SF | 58 /72 | 34.4 96 | 29.1 95 | +2.3 92 | +0.0 64 | +2.3 92 | 7.3 92 | 58.9 67 | 4.0 56 | 15.2 55 | 16.2 72 | 11.5 51 | 1.7 69 | 1.5 51 | |||||
2020
· 23 BOS · SG | 57 /72 | 33.9 94 | 24.5 87 | +1.4 87 | +0.4 74 | +1.8 88 | 6.2 90 | 58.4 67 | 3.5 50 | 16.8 64 | 9.5 40 | 11.2 65 | 1.7 66 | 1.0 31 | |||||
2019
· 22 BOS · SG | 74 /82 | 25.9 69 | 21.6 76 | −1.3 44 | +0.8 82 | −0.5 62 | 3.2 71 | 54.7 46 | 3.5 53 | 13.8 49 | 7.9 27 | 10.1 69 | 1.7 72 | 1.5 54 | |||||
2018
· 21 BOS · SG | 70 /82 | 30.7 85 | 20.8 71 | +0.3 76 | +1.6 92 | +1.9 89 | 7.2 89 | 56.6 62 | 3.4 51 | 14.0 49 | 8.1 30 | 12.2 52 | 1.6 59 | 1.0 39 | |||||
2017
· 20 BOS · SF | 78 /82 | 17.2 41 | 17.6 47 | −2.4 19 | −0.5 35 | −2.9 18 | 0.1 24 | 54.4 52 | 3.8 53 | 14.7 54 | 7.7 31 | 12.6 48 | 1.3 39 | 1.1 44 | |||||
Season · Age | GP | MPG | USG | OFF | DEF | EPM | EW | TS% | eFG% | Rim% | Mid% | 3PT% | FT% | OR% | DR% | AST% | TO% | ST% | BL% |
Date Result | MIN Poss | PTS TS% | REB | AST | STL | BLK | PF | TO | ORB | DRB | FT | eFG% | Rim | Mid | 3P% | EPM* | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thu, Feb 20 @PHI W 124-104 | 27 56 | 20 67% | 6 | 6 | 0 | 0 | 1 | 3 | 3 | 3 | 4 / 4 100% | 62% 13 FGA | 3 / 4 75% | 2 / 3 67% | 2 / 6 33% | +2.7 | ||||
Wed, Feb 12 SAS W 116-103 | Right Knee; Soreness | |||||||||||||||||||
Mon, Feb 10 @MIA W 103-85 | Right Knee; Swelling | |||||||||||||||||||
Sat, Feb 8 @NYK W 131-104 | 32 63 | 12 40% | 3 | 5 | 3 | 1 | 3 | 4 | 1 | 2 | 2 / 2 100% | 36% 14 FGA | 1 / 2 50% | 4 / 9 44% | 0 / 3 0% | +0.4 | ||||
Thu, Feb 6 DAL L 120-127 | 33 67 | 25 74% | 5 | 2 | 1 | 0 | 1 | 3 | 0 | 5 | 4 / 4 100% | 66% 16 FGA | 1 / 2 50% | 5 / 10 50% | 3 / 4 75% | +1.9 | ||||
Tue, Feb 4 @CLE W 112-105 | 28 60 | 16 67% | 9 | 6 | 0 | 0 | 5 | 5 | 2 | 7 | 2 / 2 100% | 58% 12 FGA | 5 / 6 83% | 2 / 6 33% | 0 / 0 | −0.3 | ||||
Sun, Feb 2 @PHI W 118-110 | 42 83 | 21 58% | 10 | 6 | 1 | 0 | 4 | 2 | 3 | 7 | 1 / 2 50% | 59% 17 FGA | 3 / 6 50% | 4 / 4 100% | 2 / 7 29% | +3.9 | ||||
Fri, Jan 31 @NOP W 118-116 | 35 75 | 28 70% | 6 | 4 | 0 | 0 | 4 | 1 | 1 | 5 | 3 / 4 75% | 69% 18 FGA | 3 / 4 75% | 5 / 8 63% | 3 / 6 50% | +4.3 | ||||
Wed, Jan 29 CHI W 122-100 | 36 77 | 28 61% | 6 | 6 | 1 | 0 | 3 | 0 | 0 | 6 | 7 / 11 64% | 58% 18 FGA | 5 / 7 71% | 4 / 6 67% | 1 / 5 20% | +5.2 | ||||
Mon, Jan 27 HOU L 112-114 | 38 74 | 28 56% | 4 | 4 | 0 | 1 | 4 | 2 | 0 | 4 | 5 / 6 83% | 50% 23 FGA | 0 / 0 | 7 / 14 50% | 3 / 9 33% | −1.1 | ||||
Sat, Jan 25 @DAL W 122-107 | 31 64 | 22 48% | 8 | 6 | 0 | 0 | 4 | 0 | 1 | 7 | 2 / 6 33% | 48% 21 FGA | 2 / 2 100% | 8 / 14 57% | 0 / 5 0% | +1.3 | ||||
Thu, Jan 23 @LAL L 96-117 | 33 65 | 17 43% | 8 | 3 | 1 | 0 | 2 | 0 | 2 | 6 | 0 / 3 0% | 45% 19 FGA | 1 / 5 20% | 3 / 5 60% | 3 / 9 33% | −0.8 | ||||
Wed, Jan 22 @LAC W 117-113 | 39 80 | 25 66% | 2 | 6 | 3 | 1 | 4 | 5 | 0 | 2 | 7 / 9 78% | 60% 15 FGA | 3 / 4 75% | 3 / 9 33% | 2 / 2 100% | −3.1 | ||||
Mon, Jan 20 @GSW W 125-85 | 29 58 | 17 61% | 4 | 2 | 0 | 0 | 2 | 2 | 1 | 3 | 0 / 0 | 61% 14 FGA | 3 / 5 60% | 4 / 6 67% | 1 / 3 33% | +2.1 | ||||
Date Result | MIN Poss | PTS TS% | REB | AST | STL | BLK | PF | TO | ORB | DRB | FT | eFG% | Rim | Mid | 3P% | EPM* |